Acta Med. 2006, 49: 101-104
https://doi.org/10.14712/18059694.2017.119
Serum Adenosine Deaminase Activity in Monitoring Disease Activity and Response to Therapy in Severe Psoriasis
References
1. A, Harkness RA. Adenosine deaminase activity in thymus and other human tissues. Clin Exp immunol 1976; 26:647–9.
2. C, Mabritto i, Ghio P, Solidoro P, Marchetti L, Pozzi E. Adenosine deaminase activity and fibronectin levels in bronchoalveolar lavage fluid in sarcoidosis and tuberculosis. Sarcoidosis 1993; 10:18–25.
3. BS, Fry L. The immunology of psoriasis. Br J Dermatol 1992; 126:1–9.
<https://doi.org/10.1111/j.1365-2133.1992.tb08394.x>
4. G, Beckman L, Cedergren B, Liden S. Red cell enzyme types in psoriasis. Hum Hered 1977; 27:408–11.
<https://doi.org/10.1159/000152902>
5. G, Akan T, Ciliv G. Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study. Eur J Dermatol. 2000; 10:274–6.
6. Giusti G, Galanti B. Colorimetric method. In: Methods of Enzymatic Analysis (Bergmeyer HU, ed.). Weinheim: Verlag Chemie, 1984: 315–23.
7. H, Koizumi H, Kimura T, Miura Y. Adenosine deaminase activity in peripheral lymphocytes of psoriasis and Sézary’s syndrome. J Dermatol 1980; 7: 165–9.
<https://doi.org/10.1111/j.1346-8138.1980.tb03528.x>
8. O, Karnak D, Delibalta M, Beder S, Karaca L, Tutkak H. Adenosine deaminase activity in bronchoalveolar lavage in Turkish patients with smear negative pulmonary tuberculosis. Respir Med 2002; 96:536–41.
<https://doi.org/10.1053/rmed.2001.1284>
9. H, iizuka H, Aoyagi T, Miura Y. Adenosine deaminase in human epidermis from healthy and psoriatic subjects. Arch Dermatol Res 1983; 275:340–4.
<https://doi.org/10.1007/BF00417203>
10. H, Ohkawara A. Adenosine deaminase activity in sera of patients with psoriasis, mycosis fungoides and adult T cell leukemia. Acta Derm Venereol (Stockh) 1992; 72:410–12.
11. K, Utas S, Yazici C, Akdas A, Kelestimur F. Effect of propylthiouracil on adenosine deaminase activity and thyroid function in patients with psoriasis. Br J Dermatol 2001; 144:1121–6.
<https://doi.org/10.1046/j.1365-2133.2001.04221.x>
12. R, Barton SP, Shuttleworth D, Finlay AY. Assessment of disease progress in psoriasis. Arch Dermatol 1989; 125:235–40.
<https://doi.org/10.1001/archderm.1989.01670140087017>
13. P, Filipe P, Emerit i, Freitas J, Guerra Rodrigo F, Manso C. Adenosine deaminase in progressive systemic sclerosis. Acta Derm Venereol. 1995; 75:297–9.
14. S, Russo M, Pizzella T, Galanti B. Selectively increased adenosine deaminase levels in T cells during typhoid fever. J Clin Lab immunol 1984; 14: 103–5.
15. T, Nakajima H. Serum adenosine deaminase activity in systemic sclerosis (scleroderma) and related disorders. J Am Acad Dermatol 1992; 27:411–4.
<https://doi.org/10.1016/0190-9622(92)70209-X>
16. T, Hasegawa Y, Saito H, Yamori S, Shimokata K. Adenosine deaminase isozymes in tuberculous pleural effusion. J Lab Clin Med 1996; 127:348–52.
<https://doi.org/10.1016/S0022-2143(96)90182-1>
17. H, Stanton A, Davis BH. Adenosine deaminase activity in lymphoid subpopulations and leukemias. Cancer Res 1981; 41:3107–10.
18. Yu V, Markusheva Li, Toguzov RT. Metabolism of purine compounds in psoriasis. Klin Lab Diagn 1998; 3:3–6.
19. F, Mikulikova D. The effect of methotrexate on activity of T-lymphocyte marker enzymes in patients with psoriasis vulgaris. Bratisl Lek Listy 1995; 96: 137–40.
20. JJ. Commentary: cyclic adenosine monophosphate regulation of normal and psoriatic epidermis. Arch Dermatol 1982; 118:869–74.


